Literature DB >> 33710594

Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns.

Paola Concolino1, Rosa Maria Paragliola2,3.   

Abstract

BACKGROUND AND
OBJECTIVE: Congenital adrenal hyperplasia involves a series of autosomal recessive disorders where adrenal steroidogenesis is affected. We present a detailed molecular investigation of 13 newborns affected from the severe form of congenital adrenal hyperplasia related to 21-hydroxylase deficiency.
METHODS: All patients were diagnosed with classical congenital adrenal hyperplasia in the neonatal period due to adrenal crisis and/or ambiguous genitalia presentation. None of the infants was identified through a congenital adrenal hyperplasia newborn screening program. A molecular analysis of the CYP21A2 gene and a familiar segregation analysis were performed.
RESULTS: Adrenal crisis was the most severe manifestation in the male salt-wasting newborns while all female patients presented with atypical genitalia. Newborns were correctly genotyped and no genotype-phenotype divergences were found. Two novel severe genotypes, not previously reported, were identified. The novel CYP21A2 frameshift mutations (c.793delG and c.297dupG) were added to the other 45 variants recently reported in the literature, leading to a total count of 279 pathogenic variants affecting the gene.
CONCLUSIONS: We have successfully genotyped 13 infants diagnosed with classical congenital adrenal hyperplasia after birth. Our molecular approach led to the identification of two novel frameshift CYP21A2 pathogenic variants related to the salt-wasting form of congenital adrenal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33710594     DOI: 10.1007/s40291-021-00520-y

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  57 in total

Review 1.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

2.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Newborn screening for congenital adrenal hyperplasia in the Netherlands.

Authors:  H J Van der Kamp; K Noordam; B Elvers; M Van Baarle; B J Otten; P H Verkerk
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

Review 4.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P C White; P W Speiser
Journal:  Endocr Rev       Date:  2000-06       Impact factor: 19.871

Review 5.  MANAGEMENT OF ENDOCRINE DISEASE: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update on the management of adult patients and prenatal treatment.

Authors:  Anne Bachelot; Virginie Grouthier; Carine Courtillot; Jérôme Dulon; Philippe Touraine
Journal:  Eur J Endocrinol       Date:  2017-01-23       Impact factor: 6.664

6.  Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.

Authors:  Sebastian Gidlöf; Anna Wedell; Claes Guthenberg; Ulrika von Döbeln; Anna Nordenström
Journal:  JAMA Pediatr       Date:  2014-06       Impact factor: 16.193

Review 7.  Non-classic congenital adrenal hyperplasia.

Authors:  Selma Feldman Witchel
Journal:  Steroids       Date:  2013-04-28       Impact factor: 2.668

Review 8.  Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Alan A Parsa; Maria I New
Journal:  J Steroid Biochem Mol Biol       Date:  2016-07-02       Impact factor: 4.292

9.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

View more
  1 in total

Review 1.  Genes and Pseudogenes: Complexity of the RCCX Locus and Disease.

Authors:  Cinzia Carrozza; Laura Foca; Elisa De Paolis; Paola Concolino
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.